Sae Yeon Lee

Title: Sae Yeon Lee: Pharmaceutical Crystalline-Form Innovation

Introduction

Sae Yeon Lee is an inventor based in Seoul, South Korea, whose patent work concerns the stability and practical formulation of a pharmaceutical compound. The supplied information identifies her as a woman and lists Mitoimmune Therapeutics Inc. as her company.

Latest Patents

Lee is associated with 1 patent, titled “Crystalline Forms of 5-[(1,1-Dioxido-4-Thiomorpholinyl)Methyl]-2-Phenyl-N-(Tetrahydro-2H-Pyran-4-Yl)-1H-Indol-7-Amine.” The invention describes Crystalline Form A of the compound and reports physical and chemical advantages over its amorphous and other crystalline forms. According to the patent description, the form resists denaturation under prolonged harsh conditions, absorbs little water, and remains unchanged during pressure or pulverization. Its stability is presented as beneficial for formulation and extended storage.

Career Highlights

The available information connects Lee’s inventive work with pharmaceutical solid-state chemistry, particularly the development of a stable crystalline form intended to support formulation and storage. Her listed company is Mitoimmune Therapeutics Inc.

Collaborations

The supplied information names Sang Kweon Jeon and Eun Kyung Yoo as Lee’s coworkers. Their specific roles in the patent or related research are not provided.

Conclusion

Sae Yeon Lee’s listed patent focuses on a stable crystalline form with properties intended to improve the handling, formulation, and storage of a pharmaceutical compound.